Prevention of postoperative venous thromboembolism: an update (Q40641987)

22 September 2017

1 reference

title

Prevention of postoperative venous thromboembolism: an update (English)

1 reference

22 September 2017

main subject

venous thromboembolism

1 reference

Clagett GP

1

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

The American Journal of Surgery

22 September 2017

published in

1 reference

22 September 2017

volume

168

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

515-522

1 reference

Natural history of pulmonary embolism

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Fatal pulmonary emboli in hospitalized patients. An autopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. Report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prophylaxis of venous thromboembolism: analysis of cost effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

The economics of general thromboembolic prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Venous thromboembolism prophylaxis: a survey of its use in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of venous thromboembolism. A survey of methods used by orthopaedic and general surgeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of postoperative deep vein thrombosis in Sweden: results of a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Orthopaedic surgeons and thromboprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Physician practices in the prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Pulmonary embolism in surgical patients: 1959-79.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Mortality from pulmonary embolism in the United States: 1962 to 1984

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Heparin-associated thrombocytopenia: a critical review and pooled analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Epidemiology of Venous Thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Risk factors for pulmonary embolism. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

7 January 2021

Hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Venous thrombosis after elective hip replacement—the influence of preventive intermittent calf compression and of surgical technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Heparin, deep venous thrombosis, and trauma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Acute spinal cord injuries and the incidence of clinically occurring thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

Prophylaxis of thromboembolism in spinal cord-injured patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980114-X

10.1016/S0002-9610(05)80114-X

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference